Israeli oncology treatment developer cCam Medical Ltd has developed CM-10, an immune-modulating antibody, whose anticancer effect has been demonstrated in multiple pre-clinical tests. cCam has just raised $3million to fund further trials.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000747351&fid=1725